Rocklatan Solution/ Drops
Product Images NDC 70727-529

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocklatan (NDC 70727-529). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alcon Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Netarsudil Mesylate (Image 01)

FDA Label Image

The Chemical Structure Of Latanoprost (Image 02)

FDA Label Image

Figure 1 (Image 03)

FDA Label Image

Figure 2 (Image 04)

FDA Label Image

Rocklatan (netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Carton Label (Image 05)

Rocklatan (netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Carton Label (Image 05)
This is a medication for the eyes called Rocklatan. It is used for treating high pressure in the eyes. The medication comes in a bottle and should be stored at specific temperatures before and after opening. The dosage is one drop per affected eye once a day before bedtime. The medication contains benzalkonium chloride as a preservative and water for injection. It is manufactured by Rigel Pharmaceuticals Inc.*
FDA Label Image

Rocklatan (netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Sample Carton Label (Image 06)

Rocklatan (netarsudil And Latanoprost Ophthalmic Solution) 0.02%/0.005% Sample Carton Label (Image 06)
Rocklatan is an ophthalmic solution used for topical application in the eye. It contains active ingredients such as netarsudil mesylate and latanoprost. Each mL of Rockiatan contains benzalkonium chloride as a preservative, mannitol, boric acid, sodium hydroxide to adjust pH, and water for injection. The usual dosage is one drop in the affected eye(s) once daily in the evening. The product should be stored at 2°C-8°C until opened and then can be kept at 2°C-26°C for up to 6 weeks. After opening, the expiration date should be checked before use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.